IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer

This study has suspended participant recruitment.
(Because of approval of Bevacizumab, it was difficult to perform clinical study in 1st line setting.)
Sponsor:
Collaborator:
Hokkaido University Hospital
Information provided by:
Hokkaido Gastrointestinal Cancer Study Group
ClinicalTrials.gov Identifier:
NCT00316745
First received: April 19, 2006
Last updated: October 31, 2007
Last verified: October 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: March 2009
  Estimated Primary Completion Date: No date given